Australia In Vitro Diagnostics Market Size, Growth | 2031

Segments - Australia in Vitro Diagnostics Market by Types of Products (Reagents, Instruments, and Other Types of Product), Test Types (Clinical Chemistry, Haematology, Immuno Diagnostics, Molecular Diagnostics, and Other Test Types), Applications (Cardiology, Diabetes, Oncology, Infectious Diseases, Autoimmune Disease, and Other Applications), End-users (Hospitals and Clinics, Diagnostics Laboratories, and Other End-users) - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031

Author : Raksha Sharma

Fact-checked by : Vineet Pandey

Editor : Vishal Golekar

Report Description

Australia in Vitro Diagnostics Market Outlook 2031

The Australia in vitro diagnostics market size was USD 1.27 Billion in 2022 and is projected to reach USD 1.57 Billion by 2031 expand at a considerable CAGR 2.35% during the forecast period, 2023–2031. The growth of the market is attributed to the rising geriatric population and increase in incidences of infectious and chronic diseases which requires number of in vitro diagnostics test.

In vitro diagnostic are tests which detects the infections, conditions, and diseases to help, cure and prevent from diseases. It requires assays and reagents to diagnose a medical condition. It analyzes tissue samples and body fluids collected from a patient. The tests can be conducted in health care facilities, laboratories or even in home. It consists of next generation sequencing tests which scans a person’s DNA to detect genomic variations.

In vitro diagnostics requires technical expertise for performing function hence it is used in specialized medical facilities to carry out diagnosis. In vitro diagnostics are used to check basic body functions which were not urgently required during the lockdown. Launch of in vitro diagnostics for covid-19 positively impacted the Australia in vitro diagnostic market.

Australia in Vitro Diagnostics Market Trends, Drivers, Restraints, and Opportunities

Rapid growth of the healthcare industry is key factor propelling the market during the forecast period.
Increase in use of personalized medicines for various treatments is anticipated to boost the market.
Development of automated in vitro diagnostic system for hospitals and laboratories is estimated to spur the market.
Strict government regulation and policies is expected to hamper the market in the coming years.
High cost of in vitro diagnostics tests products act as major factor that can impede the market during the forecast period.
R&D investment and technological advancement associated with in vitro diagnostics products & software is projected to create immense opportunities for the market players.

Scope of In Vitro Diagnostics Market Report

The report on the Australia in vitro diagnostics market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes	Details
Report Title	In vitro Diagnostics Market - Australia Industry Analysis, Growth, Share, Size, Trends, and Forecast
Base Year	2022
Historic Data	2016–2021
Forecast Period	2023–2031
Segmentation	Types of Products (Reagents, Instruments, and Other Types of Product), Test Types (Clinical Chemistry, Haematology, Immuno Diagnostics, Molecular Diagnostics, and Other Test Types), Applications (Cardiology, Diabetes, Oncology, Infectious Diseases, Autoimmune Disease, and Other Applications), End-Users (Hospitals and Clinics, Diagnostics Laboratories, and Other End-users)
Country	Australia
Report Coverage	Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
Key Players Covered in the Report	Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Abbott, BioMerieux SA, and Becton, Dickinson and Company

In Vitro Diagnostics Market Segment Insights

The reagents segment is projected to account for a large market share

Based on type of products, the Australia in vitro diagnostics market is divided into reagents, instruments, and other types of product. The reagents segment is expected to represent a key share of the market during the forecast period owing to accurate, rapid, and sensitive devices. Rising demand for self-testing and point-of-care products, high usage in in-vitro diagnostic testing, rise in number of R&D initiatives pertaining to reagents are anticipated to boost the market.

The immuno diagnostics segment is projected to hold a key market share

On the basis of test types, the Australia in vitro diagnostics market is segmented into clinical chemistry, haematology, immuno diagnostics, molecular diagnostics, and other test types. The immuno diagnostics segment is expected to constitute a key share of the market in the coming years due to wide usage in the detection of infectious microbes including bacteria, fungus, and viruses by detecting their toxins.

Immuno diagnostics is highly accurate in detecting the diseases. However, the clinical chemistry segment is anticipated to expand at a rapid pace during the forecast period owing to practical application of biochemistry and high usage in analyzing body fluids for therapeutic and diagnostics purposes.

The infectious diseases segment is projected to constitute a major market share

In terms of applications, the Australia in vitro diagnostics market is segregated into cardiology, diabetes, oncology, infectious diseases, autoimmune disease, and other applications.

The infectious diseases segment is expected to hold a key share of the market during the forecast period owing to increasing incidences of hepatitis, pneumonia, tuberculosis, HIV-AIDS, and other infectious diseases. Development of infectious diseases detection assays by key players for in vitro diagnostics is estimated to fuel the market.

Australia In Vitro Diagnostics Market Applications

The hospitals and clinics segment is projected to represent a large market share

Based on end-users, the Australia in vitro diagnostics market is fragmented into hospitals and clinics, diagnostics laboratories, and other end-users. The hospitals and clinics segment is expected to account for a key share of the market in the coming years due to rise in hospitalization as doctors need diagnostics interpretation for further treatment. The development of hospital infrastructure to increase the hospital facilities is expected to drive the market.

Segments

The Australia in vitro diagnostics market has been segmented on the basis of

Type of Product

Reagents
Instruments
Other Types of Product

Test Type

Clinical Chemistry
Haematology
Immuno Diagnostics
Molecular Diagnostics
Other Test Types

Application

Cardiology
Diabetes
Oncology
Infectious Diseases
Autoimmune Disease
Other Applications

End-User

Hospitals and Clinics
Diagnostics Laboratories
Other End-users

Key Players

Bio-Rad Laboratories, Inc.
F. Hoffmann-La Roche Ltd
Abbott
BioMerieux SA
Becton
Dickinson and Company

Competitive Landscape

Key players competing in the Australia in vitro diagnostics market include Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Abbott, BioMerieux SA, and Becton, Dickinson and Company.

Some of these players are engaged in several market strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to enhance their market shares.

Australia In Vitro Diagnostics Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. In Vitro Diagnostics Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. In Vitro Diagnostics Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. In Vitro Diagnostics Market - Supply Chain
  4.5. Global In Vitro Diagnostics Market Forecast
     4.5.1. In Vitro Diagnostics Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. In Vitro Diagnostics Market Size (000â€™ Units) and Y-o-Y Growth
     4.5.3. In Vitro Diagnostics Market Absolute $ Opportunity
5. Global In Vitro Diagnostics Market Analysis and Forecast by Applications
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Applications
     5.2.2. Y-o-Y Growth Projections by Applications
  5.3. In Vitro Diagnostics Market Size and Volume Forecast by Applications
     5.3.1. Cardiology Diabetes Oncology Infectious Diseases Autoimmune Disease Other Applications
  5.4. Absolute $ Opportunity Assessment by Applications
  5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global In Vitro Diagnostics Market Analysis and Forecast by End Users
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by End Users
     6.2.2. Y-o-Y Growth Projections by End Users
  6.3. In Vitro Diagnostics Market Size and Volume Forecast by End Users
     6.3.1. Hospitals and Clinics Diagnostics Laboratories Other End-users
  6.4. Absolute $ Opportunity Assessment by End Users
  6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global In Vitro Diagnostics Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. In Vitro Diagnostics Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global In Vitro Diagnostics Demand Share Forecast, 2019-2026
8. North America In Vitro Diagnostics Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America In Vitro Diagnostics Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America In Vitro Diagnostics Market Size and Volume Forecast by Applications
     8.4.1. Cardiology Diabetes Oncology Infectious Diseases Autoimmune Disease Other Applications
  8.5. Basis Point Share (BPS) Analysis by Applications
  8.6. Y-o-Y Growth Projections by Applications
  8.7. North America In Vitro Diagnostics Market Size and Volume Forecast by End Users
     8.7.1. Hospitals and Clinics Diagnostics Laboratories Other End-users
  8.8. Basis Point Share (BPS) Analysis by End Users
  8.9. Y-o-Y Growth Projections by End Users
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America In Vitro Diagnostics Demand Share Forecast, 2019-2026
9. Latin America In Vitro Diagnostics Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America In Vitro Diagnostics Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America In Vitro Diagnostics Market Size and Volume Forecast by Applications
     9.4.1. Cardiology Diabetes Oncology Infectious Diseases Autoimmune Disease Other Applications
  9.5. Basis Point Share (BPS) Analysis by Applications
  9.6. Y-o-Y Growth Projections by Applications
  9.7. Latin America In Vitro Diagnostics Market Size and Volume Forecast by End Users
     9.7.1. Hospitals and Clinics Diagnostics Laboratories Other End-users
  9.8. Basis Point Share (BPS) Analysis by End Users
  9.9. Y-o-Y Growth Projections by End Users
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America In Vitro Diagnostics Demand Share Forecast, 2019-2026
10. Europe In Vitro Diagnostics Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe In Vitro Diagnostics Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe In Vitro Diagnostics Market Size and Volume Forecast by Applications
     10.4.1. Cardiology Diabetes Oncology Infectious Diseases Autoimmune Disease Other Applications
  10.5. Basis Point Share (BPS) Analysis by Applications
  10.6. Y-o-Y Growth Projections by Applications
  10.7. Europe In Vitro Diagnostics Market Size and Volume Forecast by End Users
     10.7.1. Hospitals and Clinics Diagnostics Laboratories Other End-users
  10.8. Basis Point Share (BPS) Analysis by End Users
  10.9. Y-o-Y Growth Projections by End Users
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe In Vitro Diagnostics Demand Share Forecast, 2019-2026
11. Asia Pacific In Vitro Diagnostics Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific In Vitro Diagnostics Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific In Vitro Diagnostics Market Size and Volume Forecast by Applications
     11.4.1. Cardiology Diabetes Oncology Infectious Diseases Autoimmune Disease Other Applications
  11.5. Basis Point Share (BPS) Analysis by Applications
  11.6. Y-o-Y Growth Projections by Applications
  11.7. Asia Pacific In Vitro Diagnostics Market Size and Volume Forecast by End Users
     11.7.1. Hospitals and Clinics Diagnostics Laboratories Other End-users
  11.8. Basis Point Share (BPS) Analysis by End Users
  11.9. Y-o-Y Growth Projections by End Users
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific In Vitro Diagnostics Demand Share Forecast, 2019-2026
12. Middle East & Africa In Vitro Diagnostics Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa In Vitro Diagnostics Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa In Vitro Diagnostics Market Size and Volume Forecast by Applications
     12.4.1. Cardiology Diabetes Oncology Infectious Diseases Autoimmune Disease Other Applications
  12.5. Basis Point Share (BPS) Analysis by Applications
  12.6. Y-o-Y Growth Projections by Applications
  12.7. Middle East & Africa In Vitro Diagnostics Market Size and Volume Forecast by End Users
     12.7.1. Hospitals and Clinics Diagnostics Laboratories Other End-users
  12.8. Basis Point Share (BPS) Analysis by End Users
  12.9. Y-o-Y Growth Projections by End Users
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa In Vitro Diagnostics Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global In Vitro Diagnostics Market: Market Share Analysis
  13.2. In Vitro Diagnostics Distributors and Customers
  13.3. In Vitro Diagnostics Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. Bio-Rad Laboratories, Inc. F. Hoffmann-La Roche Ltd Abbott BioMerieux SA Becton Dickinson and Company